Corylus americana (American Hazelnut)
Corylus americana is a wild-harvested nut native to eastern North America whose bark and leaves contain taxane-class diterpenoids, including precursors to paclitaxel, that disrupt microtubule dynamics in rapidly dividing cells. Its catechins, proanthocyanidins, and flavonols also upregulate superoxide dismutase activity, reducing oxidative stress at the cellular level.

Origin & History
Corylus americana (American Hazelnut) is a deciduous shrub native to North America that produces edible nuts similar to European hazelnuts. The nuts, shells, skins, and leaves are processed through grinding and solvent extraction using hexane and methanol to isolate bioactive compounds including taxanes and phenolics.
Historical & Cultural Context
Hazelnut leaf and bark from Corylus species have been used in traditional Swedish medicine to treat pain. Specific historical use of Corylus americana in Native American or other traditional systems is not documented in available research.
Health Benefits
• Contains anticancer taxanes (paclitaxel precursors) that inhibit cancer cell proliferation - based on cellular studies only • Demonstrates antioxidant effects by enhancing superoxide dismutase and reducing reactive oxygen species - shown in HUVEC cell studies • Exhibits anti-inflammatory properties by suppressing cytokines (NO, IL-1β, TNF-α, IL-6) - demonstrated in RAW264.7 macrophage cells • May support gut health through prebiotic fiber effects on microbiota - based on related European hazelnut mouse studies • Traditional use for pain relief in Swedish medicine - historical evidence only
How It Works
Taxane diterpenoids found in Corylus americana bark bind to β-tubulin subunits of microtubules, stabilizing them against depolymerization and arresting mitosis at the G2/M phase, a mechanism analogous to pharmaceutical paclitaxel. Phenolic compounds including quercetin and catechins activate Nrf2/ARE signaling, upregulating endogenous antioxidant enzymes such as superoxide dismutase (SOD) and catalase while scavenging reactive oxygen species (ROS). Anti-inflammatory activity is mediated in part through suppression of NF-κB translocation and downstream reduction of pro-inflammatory cytokines including TNF-α and IL-6.
Scientific Research
No human clinical trials have been conducted specifically on Corylus americana. Related studies on European hazelnut (C. avellana) include mouse studies showing sex-dependent modulation of colonic microbiota (PMID: 36891893) and cellular studies demonstrating antioxidant and anti-inflammatory effects (PMCID: PMC9929368).
Clinical Summary
Current evidence for Corylus americana is limited exclusively to in vitro and preclinical models; no human clinical trials have been published as of 2024. Cell-based studies using human umbilical vein endothelial cells (HUVECs) demonstrated measurable reductions in ROS and increases in SOD activity following treatment with hazelnut leaf and bark extracts. Anticancer activity has been observed in cancer cell line assays, but cytotoxic effects in isolated cell systems do not reliably predict therapeutic efficacy or safety in humans. The evidence base must be characterized as preliminary, and extrapolation to human dosing or clinical outcomes is not currently supported.
Nutritional Profile
Corylus americana nuts provide a nutrient-dense profile similar to European hazelnuts (C. avellana) but with some compositional differences reflecting wild provenance. **Macronutrients (per 100 g dry kernel, approximate):** Fat: 55–65 g (predominantly monounsaturated oleic acid ~70–80% of total fatty acids; linoleic acid ~10–15%; palmitic acid ~5–7%; alpha-linolenic acid ~0.1–0.5%), Protein: 12–17 g (rich in arginine, glutamic acid, and aspartic acid), Carbohydrates: 10–17 g (dietary fiber: 8–11 g, including both soluble and insoluble fractions), Energy: ~600–650 kcal. **Minerals:** Manganese: 5–6 mg (high bioavailability as a cofactor for superoxide dismutase), Copper: 1.5–2.0 mg, Magnesium: 160–180 mg, Phosphorus: 280–320 mg, Potassium: 600–700 mg, Iron: 4–5 mg (non-heme, moderate bioavailability enhanced by co-present vitamin C in fresh catkins/leaves), Calcium: 110–140 mg, Zinc: 2.0–2.5 mg, Selenium: trace amounts (~2–4 µg). **Vitamins:** Vitamin E (primarily alpha-tocopherol: 15–25 mg/100 g, with smaller amounts of gamma-tocopherol ~1–3 mg; high bioavailability due to lipid matrix), Thiamine (B1): 0.4–0.6 mg, Riboflavin (B2): 0.1–0.15 mg, Niacin (B3): 1.5–2.0 mg, Folate: 70–115 µg, Vitamin B6: 0.5–0.6 mg, Vitamin K: ~14 µg. **Bioactive compounds:** Phenolic acids (gallic acid, caffeic acid, p-coumaric acid; total phenolics ~200–500 mg GAE/100 g in kernel, substantially higher in pellicle/skin up to 2000+ mg GAE/100 g), Proanthocyanidins (condensed tannins, concentrated in the brown skin/pellicle: 500–1500 mg/100 g skin), Flavonoids (quercetin, myricetin, and kaempferol glycosides: 10–50 mg/100 g in leaves and husks), **Taxol-related diterpenoids:** paclitaxel and 10-deacetylbaccatin III detected in bark, leaves, and shell tissues at trace levels (ng to low µg/g range; these are not present in significant quantities in the edible nut kernel itself), **Phytosterols:** beta-sitosterol (~100–130 mg/100 g), campesterol (~5–10 mg), stigmasterol (~2–5 mg) — phytosterols compete with cholesterol absorption with ~5–10% bioavailability. **Essential oil volatiles (husk/leaf):** include linalool, eugenol, and sesquiterpenes contributing to traditional aromatic and antimicrobial uses. **Bioavailability notes:** The high lipid content of the nut matrix enhances bioavailability of fat-soluble compounds (tocopherols, phytosterols, carotenoids). Phenolic compounds concentrated in the pellicle are partially bound to fiber and tannins, reducing gastrointestinal absorption to ~5–20%; roasting may increase free phenolic availability but reduces thermolabile vitamins. Mineral bioavailability is modestly reduced by phytic acid content (~0.2–0.5 g/100 g), which can be mitigated by soaking or fermentation.
Preparation & Dosage
No clinically studied dosage ranges exist for Corylus americana due to lack of human trials. Cellular studies used extract concentrations of 6.25-160 μg/mL. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
European Hazelnut, Green Tea Extract, Turmeric, Resveratrol, Quercetin
Safety & Interactions
Corylus americana is a member of the Betulaceae family, and individuals with birch pollen or tree nut allergies face a significant risk of cross-reactive allergic responses, including oral allergy syndrome or anaphylaxis. Because taxane-class compounds share a mechanism with chemotherapy drug paclitaxel, concurrent use with oncology treatments or cytotoxic drugs warrants medical supervision to avoid additive or unpredictable interactions. No formal safety data exist for use during pregnancy or lactation, and it should be avoided in these populations until evidence is established. Standardized supplement dosages have not been clinically validated, making safe upper intake levels undefined.